Spectral Medical Inc T.EDT

History tells us he is already "Full-Time" as it appears...

[SouthernTierTom]

you are ; - )

Bon apetito ...

Dr. Kellum is here with conviction

In my humble, yet educated opinion...

Remember he played a major role in our FDA phase 3 Euphrates Trial. Dr. Kellum, was the head of the Euphrates DSMB or the data safety monitoring board for bio newbies. Dr Kellum had the ultimate seat from which to view our phase 3 effort. As head of the DSMB, he was privy to detail that would allow the most complete understanding of a company's potential you could ever glean!

In my humble yet educated opinion, he had
s a very good hunch that our success has a rather high probability and there is tremendous P value in that.  Smart and highly sought after people tend to go to winners, not the store, but you can take that to the bank:~>

Best,
IG

[Domino55]

I am not a full time employee and have never worked at Spectral and I doubt that people who do post things here. I would not be surprised if employees read this board though.I am a shareholder. I do think that the company specifically noted his full time status to avoid just this misconception. full time means it will be his full time occupation. If it were not they would not have stated

[SouthernTierTom]

Oh good to know....I was referring to your status a full-time Stockhouse contributor...but declaring your lack of insider status is almost important as the bull you continue to spew. It's a pleasure to watch you "involve" yourself : - ) Please excuse my need to inform people with factual history vs. your "musings"

[Domino55]

STT - I have no idea what you are talking about but I think you are saying that you agree that Dr Kellum is a full time Spectral employee. I think. That means Spectral will benefit from his full time attention. thanks for your agreement

[SouthernTierTom]

History tells us he is already "Full-Time" as it appears... you are ; - ) Bon apetito ... Dr. Kellum is here with conviction In my humble, yet educated opinion... Remember he played a major role in our FDA phase 3 Euphrates Trial. Dr. Kellum, was the head of the Euphrates DSMB or the data safety monitoring board for bio newbies. Dr Kellum had the ultimate